“…A post hoc analysis of the MYRIAD trial, including 1586 patients using the same perioperative protocol at a single institution which represented the major contributor to the original study, found no significant difference in the primary outcome (mortality at 1 year 2.5% vs. 3.2%, p = 0.53) or in the rates of major complications, including MI, stroke, AKI, prolonged ventilation (>24 h), receipt of high-dose inotropic support (inotropic score >10), and need for mechanical circulatory support, duration of ICU LOS, hospitalization and hospital re-admission during follow-up between groups [ 63 ].…”